IQV – IQVIA Holdings Inc.
IQVIA Holdings, Inc.IQV
$215.75Name : IQVIA Holdings, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $36,742,225,920.00
EPSttm : 7.28
IQVIA Holdings, Inc.
$215.75
2.20%$4.86Float Short %
2.69
Margin Of Safety %
9
Put/Call OI Ratio
1.46
EPS Next Q Diff
-0.05
EPS Last/This Y
4.32
EPS This/Next Y
1.03
Price
220.53
Target Price
246.1
Analyst Recom
1.42
Performance Q
14.58
Relative Volume
0.98
Beta
1.36
Ticker: IQV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | IQV | 212.05 | 1.20 | 0.85 | 13096 |
| 2025-10-21 | IQV | 218.71 | 1.20 | 0.89 | 13188 |
| 2025-10-22 | IQV | 217.94 | 1.20 | 1.02 | 13424 |
| 2025-10-23 | IQV | 219.85 | 1.20 | 2.16 | 13514 |
| 2025-10-24 | IQV | 220.49 | 1.21 | 17.67 | 13713 |
| 2025-10-27 | IQV | 217.44 | 1.32 | 1.87 | 14400 |
| 2025-10-28 | IQV | 218.3 | 1.39 | 4.70 | 16401 |
| 2025-10-29 | IQV | 218.05 | 1.28 | 5.25 | 15855 |
| 2025-10-30 | IQV | 216.33 | 1.31 | 0.62 | 16184 |
| 2025-10-31 | IQV | 216.46 | 1.31 | 1.86 | 16200 |
| 2025-11-03 | IQV | 213.94 | 1.31 | 44.62 | 16204 |
| 2025-11-04 | IQV | 211.03 | 1.59 | 2.65 | 18300 |
| 2025-11-05 | IQV | 210.08 | 1.61 | 1.14 | 18497 |
| 2025-11-06 | IQV | 210.91 | 1.61 | 0.07 | 18534 |
| 2025-11-07 | IQV | 210.4 | 1.66 | 2.86 | 18363 |
| 2025-11-10 | IQV | 213.06 | 1.64 | 1.64 | 18309 |
| 2025-11-11 | IQV | 219.36 | 1.64 | 0.11 | 18319 |
| 2025-11-12 | IQV | 220.83 | 1.54 | 0.35 | 18820 |
| 2025-11-13 | IQV | 223.58 | 1.51 | 0.74 | 18973 |
| 2025-11-14 | IQV | 220.54 | 1.46 | 0.34 | 19522 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | IQV | 212.03 | 4.8 | 623.1 | 11.87 |
| 2025-10-21 | IQV | 218.67 | 4.8 | 613.0 | 11.87 |
| 2025-10-22 | IQV | 217.86 | 4.8 | 542.4 | 11.87 |
| 2025-10-23 | IQV | 219.94 | 4.8 | 569.4 | 11.87 |
| 2025-10-24 | IQV | 220.49 | 4.8 | 555.3 | 11.87 |
| 2025-10-27 | IQV | 217.47 | 4.8 | 521.7 | 11.87 |
| 2025-10-28 | IQV | 218.13 | 4.8 | 556.5 | 11.87 |
| 2025-10-29 | IQV | 217.91 | 4.8 | 547.9 | 11.87 |
| 2025-10-30 | IQV | 216.47 | 4.8 | 459.2 | 11.87 |
| 2025-10-31 | IQV | 216.46 | 9.0 | 500.4 | 11.90 |
| 2025-11-03 | IQV | 213.93 | 9.0 | 645.9 | 11.90 |
| 2025-11-04 | IQV | 211.02 | 9.0 | 642.2 | 11.89 |
| 2025-11-05 | IQV | 210.08 | 9.0 | 662.4 | 11.89 |
| 2025-11-06 | IQV | 210.92 | 8.8 | 666.1 | 11.89 |
| 2025-11-07 | IQV | 210.46 | 8.8 | 653.7 | 11.89 |
| 2025-11-10 | IQV | 213.05 | 8.8 | 684.5 | 11.89 |
| 2025-11-11 | IQV | 218.53 | 8.8 | 713.7 | 11.89 |
| 2025-11-12 | IQV | 220.86 | 8.8 | 681.1 | 11.89 |
| 2025-11-13 | IQV | 223.54 | 8.8 | 684.2 | 11.89 |
| 2025-11-14 | IQV | 220.53 | 8.8 | 628.1 | 11.89 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | IQV | -0.43 | 4.85 | 2.67 |
| 2025-10-21 | IQV | -0.43 | 4.85 | 2.67 |
| 2025-10-22 | IQV | -0.43 | 4.85 | 2.67 |
| 2025-10-23 | IQV | -0.43 | 4.85 | 2.67 |
| 2025-10-24 | IQV | -0.43 | 4.85 | 2.67 |
| 2025-10-27 | IQV | -0.43 | 4.82 | 2.81 |
| 2025-10-28 | IQV | -0.43 | 4.82 | 2.81 |
| 2025-10-29 | IQV | -0.42 | 4.82 | 2.81 |
| 2025-10-30 | IQV | -0.42 | 4.82 | 2.81 |
| 2025-10-31 | IQV | -4.23 | 4.82 | 2.81 |
| 2025-11-03 | IQV | -4.37 | 4.53 | 2.81 |
| 2025-11-04 | IQV | -4.37 | 4.53 | 2.81 |
| 2025-11-05 | IQV | -4.37 | 4.53 | 2.81 |
| 2025-11-06 | IQV | -4.37 | 4.53 | 2.81 |
| 2025-11-07 | IQV | -4.37 | 4.53 | 2.81 |
| 2025-11-10 | IQV | -4.27 | 3.96 | 2.81 |
| 2025-11-11 | IQV | -4.27 | 3.96 | 2.81 |
| 2025-11-12 | IQV | -4.27 | 3.96 | 2.69 |
| 2025-11-13 | IQV | -4.27 | 3.96 | 2.69 |
| 2025-11-14 | IQV | -4.27 | 3.96 | 2.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3
Avg. EPS Est. Current Quarter
3.4
Avg. EPS Est. Next Quarter
2.95
Insider Transactions
-4.27
Institutional Transactions
3.96
Beta
1.36
Average Sales Estimate Current Quarter
4240
Average Sales Estimate Next Quarter
4078
Fair Value
239.32
Quality Score
67
Growth Score
86
Sentiment Score
85
Actual DrawDown %
22.8
Max Drawdown 5-Year %
-51.5
Target Price
246.1
P/E
30.29
Forward P/E
17.08
PEG
3.48
P/S
2.36
P/B
6.1
P/Free Cash Flow
16.99
EPS
7.28
Average EPS Est. Cur. Y
11.89
EPS Next Y. (Est.)
12.92
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
8.07
Relative Volume
0.98
Return on Equity vs Sector %
-6.1
Return on Equity vs Industry %
9.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
628.1
IQVIA Holdings, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 91000
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
stock quote shares IQV – IQVIA Holdings Inc. Stock Price stock today
news today IQV – IQVIA Holdings Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IQV – IQVIA Holdings Inc. yahoo finance google finance
stock history IQV – IQVIA Holdings Inc. invest stock market
stock prices IQV premarket after hours
ticker IQV fair value insiders trading